Myeloproliferative Philadelphia-Negative Syndromes

被引：0
|
作者：
Kiladjian, Jean-Jacques [1 ,2 ]
机构：
[1] Hop Avicenne, AP HP, Serv Hematol, 125 Rue Stalingrad, F-93000 Bobigny, France
[2] Univ Paris XIII, Villetaneuse, France
来源：
HEMATOLOGIE | 2007年 / 13卷
关键词：
D O I：
10.1684/hma.2007.0099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：55 / 58
页数：4
相关论文
共 50 条
  • [31] Circulating YKL-40 in Philadelphia-negative myeloproliferative neoplasms
    Krecak, Ivan
    Gveric-Krecak, Velka
    Lapic, Ivana
    Roncevic, Pavle
    Gulin, Josipa
    Fumic, Ksenija
    Krecak, Filip
    Holik, Hrvoje
    Durakovic, Nadira
    ACTA CLINICA BELGICA, 2021, 76 (01) : 32 - 39
  • [32] Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms
    Gurska, Lindsay M.
    Okabe, Rachel
    Schurer, Alexandra
    Tong, Meng Maxine
    Soto, Mark
    Choi, Daniel
    Ames, Kristina
    Glushakow-Smith, Shira
    Montoya, Allison
    Tein, Ellen
    Miles, Linde A.
    Cheng, Haiying
    Hankey-Giblin, Pamela
    Levine, Ross L.
    Goel, Swati
    Halmos, Balazs
    Gritsman, Kira
    CLINICAL CANCER RESEARCH, 2023, 29 (05) : 943 - 956
  • [33] Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives
    Bartalucci, Niccolo
    Galluzzi, Lorenzo
    CELLULAR AND MOLECULAR ASPECTS OF MYELOPROLIFERATIVE NEOPLASMS - PT A, 2021, 365 : IX - XX
  • [34] Genomic Profiling of Blast Phase in Philadelphia-Negative Myeloproliferative Neoplasms
    Roncoroni, Elisa
    Feenstra, Jelena D. Milosevic
    Rumi, Elisa
    Pietra, Daniela
    Ferretti, Virginia Valeria
    Bellini, Marta
    Cavalloni, Chiara
    Casetti, Ilaria Carola
    Jager, Roland
    Bogner, Edith
    Ciboddo, Michele
    Zappasodi, Patrizia
    Vanelli, Cristina Picone Laura
    Astori, Cesare
    Kralovics, Robert
    Cazzola, Mario
    BLOOD, 2017, 130
  • [35] Familial Philadelphia-negative myeloproliferative disorders: clinical and molecular characteristics
    Bellanne-Chantelot, Christine
    Saint-Martin, Cecile
    Malak, Sandra
    Najman, Albert
    HEMATOLOGIE, 2011, 17 (05): : 331 - 341
  • [36] Association of Hyperuricemia with Thrombosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Pulido, Mariem
    Aguilar, Elena Tuna
    Romero, Junice Teresita Sosa
    BLOOD, 2024, 144 : 6637 - 6637
  • [37] Response, complications and risk of leukemic transformation of phosphorus-32 treatment in Philadelphia-negative chronic myeloproliferative syndromes
    Larrea, I. Tobalina
    Fernandez, J. Cuetos
    Abad, A. Mendizabal
    de la Pena, A. Montero
    Hernandez, D. Garcia
    Quatrociocchi, G. H. Portilla
    Alonso, M. Jimenez
    Echevarria, M. C. Menchaca
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2025, 44 (01):
  • [38] Methylation Profiling SOCS2 in Philadelphia-Negative Myeloproliferative Neoplasm
    Yasin, Elrashed B.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (47A) : 452 - 461
  • [39] Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms
    Kennedy, James A.
    Atenafu, Eshetu G.
    Messner, Hans A.
    Craddock, Kenneth J.
    Brandwein, Joseph M.
    Lipton, Jeffrey H.
    Minden, Mark D.
    Schimmer, Aaron D.
    Schuh, Andre C.
    Yee, Karen W.
    Gupta, Vikas
    BLOOD, 2013, 121 (14) : 2725 - 2733
  • [40] Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms
    Sorensen, Anders Lindholm
    Hasselbalch, Hans Carl
    LEUKEMIA RESEARCH, 2016, 41 : 27 - 35
12345